Abu Dhabi: Khalifa Economic Zones Abu Dhabi (KEZAD) Group, the integrated trade, logistics, and industrial hub of Abu Dhabi, is set to showcase the competitive advantage the Emirate offers to researchers, manufacturers, and distributors looking at Arab Health 2023.
KEZAD, a premier economic zone for life sciences in the Middle East and North Africa, already hosts several pharmaceutical manufacturers, life science businesses, laboratories, packing businesses, and supporting services, including several leading organisations.

Mr. Mohamed Al Khadar Al Ahmad, CEO of Khalifa Economic Zones Abu Dhabi (KEZAD Group), commented that, “At Arab Health 2023, KEZAD Group will share its unique value proposition to accelerate growth and innovation within the region’s medical sector. As a leading facilitator of industry and manufacturing, KEZAD Group currently supports the operations of leading healthcare businesses via its Life Sciences Hub.”
“In addition to critical infrastructure, such as advanced cold-chain storage and blockchain management for safe and secure vaccine distribution, KEZAD Group further provides unrivalled multimodal connectivity, linking healthcare businesses to global markets with access to approximately 4.5 billion people worldwide,” the CEO added.
During the event, KEZAD Group will exhibit its capabilities for strengthening industry growth and innovation through its life science ecosystem, located in the heart of Abu Dhabi. The life science ecosystem was specifically designed for manufacturing, logistics, development, and education activities in the field.
KEZAD’s healthcare and life science ecosystem, which is spread across 1.6 square kilometres and supported by multi-modal transport links via land, sea, air, and the upcoming rail, offers fast set-up times for companies through a range of solutions.
The annual Arab Health Conference, which takes place from January 30 to February 2 at the Dubai World Trade Centre, provides a vital platform for the region’s healthcare stakeholders to exchange insights on new developments within the industry, aimed at revolutionising healthcare for future generations.